Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rBet v1-FV Immunotherapy in Birch Pollen Allergy
NCT01490411Phase 2Completed
- Sponsor
- Allergopharma
- Start
- Oct 2010
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rBet v1-FV in seasonal allergic rhinitis (SAR), sponsored by Allergopharma. Started Oct 2010; status: completed.
02
Drugs
rBet v1-FV
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01490411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490411.